Skip to content
R&D Tax Incentives

R&D Tax Incentives Hong Kong — Section 16B

Hong Kong's enhanced R&D deduction allows up to 300% deduction on qualifying R&D expenditure. Most companies significantly underutilise this — leaving hundreds of thousands on the table every year.

300%
Enhanced deduction rate (first HKD 2M)
200%
Rate on expenditure above HKD 2M
100%
Basic deduction (all qualifying R&D)

⚠ Most HK Companies Underclaim R&D Deductions

IRD's DIPN 49 defines qualifying R&D broadly — including software development, product improvement, and process R&D. Many companies expense R&D without claiming the enhanced deduction, missing the uplift that turns a 16.5% deduction into a 300% deduction on the first HKD 2 million.

Common Challenges

🔍

Identifying Qualifying Expenditure

Not all R&D spending qualifies for the enhanced rate. Wages, equipment, and contracted research at prescribed institutions qualify; market research and routine testing do not.

⚠ Risk: Overclaiming non-qualifying spend → IRD disallowance + penalties

🏛️

Prescribed Research Institutions

The 300%/200% enhanced rate applies only to R&D outsourced to prescribed research institutions (universities, innovation centres). Internal R&D gets 100% only unless the enhanced conditions are met.

⚠ Risk: Missing prescribed institution qualification → claiming 100% instead of 300%

📋

Documentation Requirements

IRD requires detailed records of R&D activities, project purpose, qualifying expenditure categorisation, and staff time allocation to support enhanced deduction claims.

⚠ Risk: Poor documentation → IRD rejects enhanced claim on audit

🌐

IP Ownership Requirement

For the enhanced rate, the R&D must be related to a trade or business carried on in HK, and any resulting IP should be owned or co-owned by the HK entity.

⚠ Risk: IP owned offshore → HK entity loses enhanced deduction entitlement

Who Is This For?

Technology and software companies

Companies developing proprietary software, apps, or platforms in HK.

Pharmaceutical and biotech firms

Life sciences companies conducting drug research, clinical trials, or formulation development.

Manufacturing companies with product R&D

Manufacturers improving products or production processes through systematic R&D.

Companies partnering with HK universities

Businesses with research collaborations with HKUST, HKU, CUHK, or PolyU.

What We Do

R&D Expenditure Review

Analyse all R&D expenditure to identify qualifying amounts for the basic and enhanced deductions under s.16B IRO.

Per DIPN 49 guidance

Enhanced Deduction Claim

Prepare the R&D enhanced deduction claim for inclusion in the profits tax return, with full documentation package.

Project summaries + expenditure schedules

Prescribed Institution Structuring

Advise on how to structure R&D partnerships with HK prescribed research institutions to maximise the 300% rate.

University collaboration agreement review

R&D Tax Planning Strategy

Develop a multi-year R&D tax strategy — identifying optimal project structures, expenditure timing, and IP ownership arrangements.

Linked to patent box planning

How It Works

1

R&D Activity Mapping

1-2 weeks

Interview technical and finance teams to map all qualifying R&D activities and expenditure.

2

Qualifying Expenditure Analysis

1 week

Categorise expenditure by qualifying type and calculate basic vs enhanced claim.

3

Documentation Preparation

1-2 weeks

Prepare R&D project summaries and supporting documentation for IRD.

4

Annual Review

Annual

Annual review to capture new R&D activity and update the deduction claim.

Case Studies

Case StudySaved HKD 660,000

Fintech company — software R&D enhanced claim

  • HKD 3.8M annual R&D expenditure identified
  • HKD 2M restructured to HKUST collaboration (300% rate)
  • Additional HKD 1.8M claimed at 200% rate
  • Total deduction: HKD 9.6M vs HKD 3.8M expensed
We were expensing R&D but never claiming the enhanced deduction. That changes everything.
Case StudySaved HKD 1,100,000

Medical device manufacturer — R&D + patent box combo

  • R&D enhanced deduction HKD 580K annual saving
  • Patent box 5% rate on resulting royalty income
  • IP ownership confirmed in HK entity
  • DEMPE substance documented for BEPS compliance
The combined R&D deduction and patent box saved us seven figures annually.

Frequently Asked Questions

What does "qualifying R&D" mean under section 16B?

Qualifying R&D under s.16B(1) includes activities that are innovative, involve technical uncertainty, are systematic or investigative in nature, and aim to advance knowledge or create new/improved products, processes, or services. Routine product testing, market research, and quality control do NOT qualify.

What is the 300% enhanced deduction and how does it work?

The first HKD 2 million of qualifying R&D expenditure paid to a prescribed research institution attracts a 300% deduction — meaning a HKD 2M payment reduces assessable profits by HKD 6M. Expenditure above HKD 2M at a prescribed institution attracts 200%. In-house R&D qualifies for 100% (basic deduction only), plus potentially 200% if conditions met.

Which are the prescribed research institutions?

The list of prescribed research institutions includes the eight HK universities (HKU, CUHK, HKUST, PolyU, CityU, HKBU, HSUHK, EdUHK), various government-funded R&D centres, and other approved institutions listed in Schedule 45 of IRO. The list is updated periodically.

Can I claim R&D deductions if I outsource to a Mainland China research lab?

Only if the Mainland lab is a prescribed research institution under HK law — which most are not. For non-prescribed institution outsourcing, only the basic 100% deduction applies (if the expenditure otherwise qualifies). Subcontracting R&D to overseas non-prescribed labs does not attract enhanced rates.

Do R&D deductions work differently for capital vs revenue expenditure?

Yes. Capital expenditure on R&D assets (equipment, machinery used for R&D) qualifies for capital allowances under s.16B(3), not the enhanced revenue deduction. Revenue expenditure (staff costs, consumables, payments to research institutions) qualifies for the enhanced deduction. The distinction requires careful analysis.

Can a startup with no profits claim R&D deductions?

R&D deductions that cannot be utilised in the year because the company has insufficient profits can be carried forward indefinitely under s.19C IRO and offset against future profits. This makes early-stage R&D expenditure valuable even when the company is loss-making.

専門的な税務サービスが必要ですか?

今すぐ専門チームにお問い合わせください。無料相談とお見積もりを提供いたします。個人・法人向けの香港税務サービスを幅広く提供しています。

無料相談

以下のフォームにご記入ください。24時間以内に専門チームがご連絡いたします。

Related Services